Skip to main navigation Skip to search Skip to main content

Treatment of primary plasma cell leukemia with high doses of cyclophosphamide, bortezomib, and dexamethasone followed by double autologous HSCT

Research output: Contribution to journalArticle

Abstract

nd
Original languageEnglish
Pages (from-to)207-209
Number of pages3
JournalAnnals of Hematology
Volume99
DOIs
Publication statusPublished - 2020

Keywords

  • plasmacell leukemia

Fingerprint

Dive into the research topics of 'Treatment of primary plasma cell leukemia with high doses of cyclophosphamide, bortezomib, and dexamethasone followed by double autologous HSCT'. Together they form a unique fingerprint.

Cite this